Mary Kay To Pay $40M Over Wrinkle Cream Patent

Law360, New York (April 6, 2006, 12:00 AM EDT) -- Makeup retailer Mary Kay Inc. has been orderd by a jury to pay TriStrata Technology Inc. $40 million for allegedly infringing patents for its skin care remedy used to treat wrinkles.

TriStrata, a subsidiary of NeoStrata Co., originally filed the lawsuit in 2001, accusing Mary Kay of using its patented alpha hydroxy acid technology.

In March 2005, a jury ordered Mary Kay to pay more than $26 million in backend royalties to Delaware-based TriStrata. TriStrata returned to court to seek interest on that amount.

The total...
To view the full article, register now.
Law360 Pro Say Podcast
Check out Law360's new podcast, Pro Say, which offers a weekly recap of both the biggest stories and hidden gems from the world of law.